Evaluation of brain pharmacokinetics of (+)MK-801 in relation to behaviour

Neuroscience Letters

Volumn 503, Issue 1, 2011, Pages 68-72

  Wegener, Nico ^a   Nagel, Jens ^a,b   Gross, Ralph ^a   Chambon, Caroline ^a   Greco, Sergio ^a   Pietraszek, Malgorzata ^a   Gravius, Andreas ^a   Danysz, Wojciech ^a  

^a MERZ PHARMACEUTICALS GMBH   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

Brain microdialysis; Cognition; MK 801; NMDA receptor; Rat; Water maze

Indexed keywords

DIZOCILPINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BEHAVIOR CHANGE; BINDING AFFINITY; BRAIN; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG HALF LIFE; IN VIVO STUDY; LOCOMOTION; MALE; MAXIMUM PLASMA CONCENTRATION; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANALYSIS OF VARIANCE; ANIMALS; AREA UNDER CURVE; BEHAVIOR, ANIMAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MAZE LEARNING; MICRODIALYSIS; PUTAMEN; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STATISTICS, NONPARAMETRIC;

EID: 80052680140     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.08.012     Document Type: Article

References (25)

1. Andine P., Widermark N., Axelsson R., Nyberg G., Olofsson U., Martensson E., Sandberg M. Characterization of MK-801-induced behavior as a putative rat model of psychosis. J. Pharmacol. Exp. Ther. 1999, 290:1393-1408.
2. Berman R.M., Cappiello A., Anand A., Oren D.A., Heninger G.R., Charney D.S., Krystal J.H. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 2000, 47:351-354.
3. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
4. Danysz W., Parsons C.G., Bresink I., Quack G. Glutamate in CNS disorders - a revived target for drug development. Drug News Perspect. 1995, 8:261-277.
5. Danysz W., Zajaczkowski W., Parsons C.G. Modulation of learning processes by ionotropic glutamate receptor ligands. Behav. Pharmacol. 1995, 6:455-474.
6. de Lange E.C., de Boer A.G., Breimer D.D. Methodological issues in microdialysis sampling for pharmacokinetic studies. Adv. Drug Deliv. Rev. 2000, 45:125-148.
7. de Lange E.C., Ravenstijn P.G., Groenendaal D., van Steeg T.J. Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling. AAPS J. 2005, 7:E532-E543.
8. Hesselink M.B., DeBoer B.G., Breimer D.D., Danysz W. Brain penetration and in vivo recovery of NMDA receptor antagonists amantadine and memantine: a quantitative microdialysis study. Pharm. Res. 1999, 16:637-642.
9. Honegger U.E., Quack G., Wiesmann U.N. Evidence for lysosomotropism of memantine in cultured human cells - cellular kinetics and effects of memantine on phospholipid content and composition, membrane fluidity and beta-adrenergic transmission. Pharmacol. Toxicol. 1993, 73:202-208.
10. Hucker H.B, Hutt J.E., White S.D., Arison B.H., Zacchei A.G. Disposition and metabolism of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine in rats, dogs, and monkeys. Drug Metab. Dispos. 1983, 11:54-58.
11. Javitt D.C., Zukin S.R. Interaction of [3H]MK-801 with multiple states of the N-methyl-d-aspartate receptor complex of rat brain. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:740-744.
12. Kornhuber J., Retz W., Riederer P. Slow accumulation of psychotropic substances in the human brain. Relationship to therapeutic latency of neuroleptic and antidepressant drugs?. J. Neural Transm. 1995, Suppl 46:315-323.
13. Li Y., Peris J., Zhong L., Derendorf H. Microdialysis as a tool in local pharmacodynamics. AAPS J. 2006, 8:E222-E235.
14. Malenka R.C. Synaptic plasticity in the hippocampus: LTP and LTD. Cell 1994, 78:535-538.
15. McLamb R.L., Williams L.R., Nanry K.P., Wilson W.A., Tilson H.A. MK-801 impedes the acquisition of a spatial memory task in rats. Pharmacol. Biochem. Behav. 1990, 37:41-45.
16. Morris R.G., Anderson E., Lynch G.S., Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-d-aspartate receptor antagonist, AP5. Nature 1986, 319:774-776.
17. Murray F., Kennedy J., Hutson P.H., Elliot J., Huscroft I., Mohnen K., Russell M.G., Grimwood S. Modulation of 3HMK-801 binding to NMDA receptors in vivo and in vitro. Eur. J. Pharmacol. 2000, 397:263-270.
18. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1997, Academic Press. 3rd Edition.
19. Reynolds I.J., Murphy S.N., Miller R.J. 3H-labeled MK-801 binding to the excitatory amino acid receptor complex from rat brain is enhanced by glycine. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:7744-7748.
20. Schmidt W.J., Kretschmer B.D. Behavioural pharmacology of glutamate receptors in the basal ganglia. Neurosci. Biobehav. Rev. 1997, 21:381-392.
21. Vezzani A., Serafini R., Stasi M.A., Caccia S., Conti I., Tridico R.V., Samanin R. Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats. J. Pharmacol. Exp. Ther. 1989, 249:278-283.
22. Wesierska M., Macias-Gonzalez R., Bures J. Differential effect of ketamine on the reference and working memory versions of the Morris water maze task. Behav. Neurosci. 1990, 104:74-83.
23. Westerink B.H. Brain microdialysis and its application for the study of animal behaviour. Behav. Brain Res. 1995, 70:103-124.
24. Wong E.H., Knight A.R., Woodruff G.N. [3H]MK-801 labels a site on the N-methyl-d-aspartate receptor channel complex in rat brain membranes. J. Neurochem. 1988, 50:274-281.
25. Zhang Y., Huo M., Zhou J., Xie S. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in microsoft excel. Comput. Methods Programs Biomed. 2010, 99:306-314.